Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Humana Inc. due to a class action lawsuit alleging breaches of fiduciary duties by the board of directors during the specified class period [1][5]. Company Overview - Humana is a health insurance company that provides medical benefit plans to its members [5]. Class Action Lawsuit Details - The class action lawsuit claims that Humana's management made false or misleading statements regarding the company's adjusted earnings-per-share, particularly downplaying the impact of increased medical costs due to pent-up demand for healthcare services as COVID-19 concerns eased [5]. - On June 13, 2023, UnitedHealth Group Inc. reported increased outpatient care activity attributed to pent-up demand, leading to an over 11% drop in Humana's stock price [5]. - Following a report on June 16, 2023, indicating higher than anticipated non-inpatient utilization trends, Humana's stock price fell again [5]. - On January 18, 2024, Humana disclosed a benefits expense ratio of approximately 91.4% for Q4 2023, resulting in nearly an 8% decline in stock price [5]. - The lawsuit also states that on January 25, 2024, Humana announced a loss of $4.42 per share for Q4 2023 due to higher inpatient utilization, causing a nearly 12% drop in stock price [5].

Core Viewpoint - UnitedHealth (UNH) shares are experiencing a positive trend following a bullish note from Wells Fargo analyst Stephen Baxter, who maintains an "Overweight" rating and raises the price target to $400, suggesting an 8% upside potential from current levels [1][2]. Group 1: Analyst Insights - Baxter's positive outlook is notable as UNH stock has increased over 50% since early August [2]. - Despite UnitedHealth's recent decision to scale back Medicare Advantage offerings affecting approximately 180,000 beneficiaries, Baxter recommends holding UNH due to its dominance in employer-sponsored and government-backed insurance, serving over 50 million members globally [3]. - The investment firm has raised its estimates for UNH's upcoming quarterly release, anticipating the extension of increased subsidies [4]. Group 2: Financial Metrics - UNH's care delivery and analytics unit, Optum, is described as a structural growth engine that provides margin resilience, countering near-term utilization pressures [5]. - Despite a significant rise in stock price, UNH shares are trading at an attractive valuation of less than 1x sales [5]. - The stock offers a healthy dividend yield of 2.39%, appealing to income-focused investors [4]. Group 3: Market Sentiment - Warren Buffett's recent disclosure of a sizable position in UnitedHealth reflects confidence in the company's long-term growth and stability [6]. - Baxter believes that the recent selloff of UnitedHealth due to regulatory scrutiny and rising medical costs is overblown, presenting a compelling entry point for long-term investors [6]. - Overall, Wall Street remains optimistic about UnitedHealth's ability to maintain momentum [8].

New Hampshire Senator Jeanne Shaheen added her voice to the chorus of Democrats, some Republicans and numerous experts sounding the alarm about the consequences of letting the Affordable Care Act (ACA) enhanced premium tax credits expire at the end of this year. The senator appeared on CNBC’s Squawk Box recently to explain how not extending the tax credits could prove a health care catastrophe for millions of Americans (1). “Failure to extend those tax credits,” she warned, “is going to see insurance cos ...

Key Takeaways Oscar shares have soared 75% since raising revenue guidance But analysts reversed course on their profit forecasts and now project lossesAverage price targets remain near $12, with Wells Fargo recently raising to $14Oscar Health ((OSCR) is a $5 billion digital health-insurance company that was expected to see a strong rise to profitability this year into 2026.But even after raising top line guidance this year to $12-12.2 billion from $11.2-11.3 billion, analysts reversed course on their EPS fo ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you suffered losses in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a lea ...

UnitedHealth Group Incorporated (UNH), headquartered in Minnetonka, Minnesota, owns and manages organized health systems. With a market cap of $324.9 billion, the company provides employers with products and resources to plan and administer employee benefit programs serving customers worldwide. The health insurance giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Tuesday, Oct. 28. Ahead of the event, analysts expect UNH to report a profit of $2.87 per sha ...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) securities between February 5, 2025 and July 23, 2025 (the “Class Period”) have until December 2, 2025 to seek appointment as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The filed complaint alleges that Molina Healthcare and certain executives violated the Securities Exchange Act of 1934 by making materia ...

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - The stock price fell by $32.03 per share, or 16.8%, from $190.25 on July 23, 2025, to $158.22 on July 24, 2025, in response to these announcements [4].

For the average American, healthcare in retirement will cost more than they have in their entire savings account. And unfortunately, Medicare won’t help. Healthcare, of course, is the single biggest line item that most retirees need to prepare for. Recently, a study released by the EBRI (the Employee Benefit Research Institute) emphasized how important that is. The institute’s data finds that despite the coverage offered by Medicare, retirees should expect to pay significant out of pocket costs for their ...

RT Rep Andy Biggs (@RepAndyBiggsAZ)The reality is that Obamacare is only affordable when it is heavily subsidized.The complete failure of the “Affordable” Care Act is why health insurance premiums have skyrocketed.That’s why I introduced a bill to completely—and responsibly—repeal Obamacare. https://t.co/fBH25FlSBU ...